Gilead Sciences (GILD) Tax Provisions (2009 - 2026)

Gilead Sciences (GILD) has reported Tax Provisions for 18 consecutive years, with $242.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions fell 48.29% year-over-year to $242.0 million; the trailing twelve-month figure through Jun 2026 stood at $940.0 million (up 5.62% YoY), and the FY2025 full-year result was $1.3 billion, up 509.48% from the prior year.
• Tax Provisions slipped to $242.0 million in Q2 2026 per GILD's latest filing, from $559.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $646.0 million in Q3 2022 and bottomed at -$450.0 million in Q4 2025.
• Historically, Tax Provisions has averaged $247.2 million across 5 years, with a median of $351.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions slumped 303.42% in 2024, then jumped 298.32% in 2025.
• Over 5 years, Tax Provisions stood at $398.0 million in 2022, then tumbled by 40.45% to $237.0 million in 2023, then surged by 62.45% to $385.0 million in 2024, then tumbled by 216.88% to -$450.0 million in 2025, then surged by 153.78% to $242.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $242.0 million, $559.0 million, and -$450.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.